Purpose: The aim of this study was to evaluate the efficacy of percutaneous radiofrequency ablation (RFA) for osteoid osteoma (OO) using cool-tip electrodes without the cooling system.
Materials And Methods: A total of 17 patients (13 males, 4 females; mean age 19.1 years; range 7-49 years) with OO (tibia, n = 7; femur, n = 5; acetabulum, n = 2; radius, n = 1; talus, n = 1; lumbar spine, n = 1) underwent RFA. Using a cool-tip electrode without the cooling system, the lesion was heated to 90°C for 4 or 5 min. Procedures were considered technically successful if the electrode was placed into the nidus and the target temperature was reached and maintained for at least 4 min. Clinical success of the treatment was defined as complete or partial pain relief after RFA.
Results: All procedures were considered technically successful, although two patients encountered complications (pes equinus contracture, skin burn). Altogether, 16 of the 17 patients (94.1%) achieved complete or partial pain relief after primary RFA. Two patients had pain recurrence, with one of them treated successfully with a second RFA. The overall clinical success rate was 88.2%. Histological findings confirmed the presence of OO in 13 patients (76.5%).
Conclusion: Percutaneous RFA of OO using cool-tip electrodes without the cooling system is a safe, effective procedure.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s11604-010-0529-7 | DOI Listing |
J Pers Med
March 2022
IInd Department of Urology, Medical University of Lodz, al. Kościuszki 4, 90-419 Łódź, Poland.
Unlabelled: Implementation of ultrasonography (USG), computed tomography (CT) and magnetic resonance imaging (MRI) into abdominal cavity diagnostics enabled early detection of cT1 graded renal cancers. According to European Association of Urology (EAU) and Polish urological Association (PUA) recommended method of treatment is sparing resection of renal parenchyma with tumour-nephron-sparing surgery (NSS). In selected cases other methods such as thermal ablation (TA) or cryoablation can be introduced /1/.
View Article and Find Full Text PDFUltrasound Med Biol
March 2022
Department of Medical Ultrasonics, First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China. Electronic address:
This pilot clinical study evaluated primarily the efficacy of feeding vessel ablation (FVA) in the treatment of hepatocellular carcinoma (HCC) located at the liver marginal angle (LMA). Nine patients with nine unresectable HCC lesions were prospectively included in this study. The target tumors (mean: 3.
View Article and Find Full Text PDFInt J Gynecol Cancer
July 2017
*Division of Interventional Ultrasound, Department of Medical Ultrasound, and †Department of Liver Surgery, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Objective: The aim of this study was to evaluate the feasibility, effectiveness, and safety of ultrasound-guided percutaneous radiofrequency ablation (RFA) for the treatment of liver metastasis from ovarian cancer (OC).
Methods: A retrospective review was performed on 11 patients (mean age, 53.0 ± 10.
Int J Hyperthermia
June 2017
a Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of ultrasound , Peking University Cancer Hospital and Institute, Beijing , China.
Purpose: To determine the incidence, risk factors and prognosis associated with needle track seeding after percutaneous radiofrequency ablations (RFA) for hepatocellular carcinoma (HCC) with a long-term follow-up.
Materials And Methods: A total of 741 HCC patients undergoing percutaneous RFA were retrospectively analysed. Mean follow-up interval was 34.
Int J Hyperthermia
June 2017
a CISR Lab , East China University of Science and Technology, Shanghai , China.
Aim: The aim of this study was to investigate the feasibility of achieving relatively large coagulation zones (i.e. ≥3 cm in diameter) with radiofrequency ablation (RFA) by using a broad control system.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!